Menopause weight gain: the influence of TSEC intervention
No abstract available (Source: Menopause)
Source: Menopause - March 31, 2016 Category: OBGYN Tags: Editorials Source Type: research

Refinement and expansion of a tool for measuring genitourinary syndrome of menopause
No abstract available (Source: Menopause)
Source: Menopause - March 31, 2016 Category: OBGYN Tags: Editorials Source Type: research

Bioidentical hormone therapy: a challenge for the menopause clinician
No abstract available (Source: Menopause)
Source: Menopause - March 31, 2016 Category: OBGYN Tags: Editorials Source Type: research

Dry eye in postmenopausal women: a hormonal disorder
Conclusions: Because of the high incidence of dry eye among postmenopausal women that may be related to the hormonal treatment, we propose that a multidisciplinary approach should be considered between gynecologists and ophthalmologists in management of this disorder. (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Review Articles Source Type: research

Hormone therapy for ovarian cancer survivors: systematic review and meta-analysis
Conclusions: Based on the results of meta-analysis, HT does not influence the odds of ovarian cancer recurrence; however, this conclusion must be confirmed separately because of significant limitations in the methodological quality of the studies included. (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Review Articles Source Type: research

Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial
Objective: To describe the efficacy and tolerability of continuous nitroglycerin for treatment of hot flashes. Methods: Perimenopausal and postmenopausal women reporting at least seven hot flashes per day were recruited into a single-arm, dose-escalation trial of continuous transdermal nitroglycerin. Participants were started on a generic 0.1 mg/hour nitroglycerin patch applied daily without patch-free periods. During 4 weeks, participants escalated dosage weekly to 0.2, 0.4, or 0.6 mg/hour as tolerated, then discontinued nitroglycerin during the final week. Changes in hot flash frequency and severity were assessed us...
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Brief Report Source Type: research

Health-related quality of life in midlife women in Qatar: relation to arthritis and symptoms of joint pain
Conclusions: Self-report of OA or RA was associated with significant disability in our sample. Because symptoms of aches and stiff joints were so frequently reported, arthritis may be under-diagnosed, especially given the high rates of obesity observed. (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine granules for the treatment of menopausal symptoms by stages
Objective: The study aims to evaluate the effectiveness and safety of Chinese herbal medicine granules Danzhi Qing’e formula (DZQE), Erzhi formula (EZ), and their combination (Combined formula) in the treatment of menopausal symptoms at different stages of menopause. Methods: Women between the ages of 40 to 60 years, who met menopausal symptoms diagnostic criteria and experienced hot flushes at least 14 times/week in the last 4 weeks, were recruited to participate in a stratified randomized, double-blind, placebo-controlled clinical trial (n = 389). They received a treatment period of 8 weeks and were followed u...
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Middle-aged female sexual dysfunction and multimorbidity: a population-based study
Objectives: The aim of the study was to evaluate the association between multimorbidity and sexual dysfunction in women aged 45 to 60 years in a cross-sectional population-based study in a specific Brazilian city. It was also to evaluate the main factors associated with sexual dysfunction in the group with multimorbidity. Methods: Cross-sectional population-based study conducted with 736 women (household survey), representative of a population of 257,434 women, to obtain data on multimorbidity and sexual dysfunction, as part of a broader study on women's health. The instrument used to evaluate sexual dysfunction was the S...
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Comparative efficacy and safety of estradiol transdermal preparations for the treatment of vasomotor symptoms in postmenopausal women: an indirect comparison meta-analysis
Conclusions: Using network meta-analysis for indirect treatment comparison, we have shown that the efficacy of Divigel 0.25 mg, as measured by reduced hot flush frequency and severity, was similar to that of Divigel 0.5 mg and of Estrogel 0.75 and 1.5 mg. Overall, our analysis showed that Divigel 1.0 mg provided the best efficacy profile, but that this treatment was also associated with a higher risk of AEs. The network meta-analysis also showed that treatment with Estrogel 1.5 mg was associated with the smallest estimate of reduction in frequency of hot flushes. (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Physical therapy for urinary incontinence in postmenopausal women with osteoporosis or low bone density: a randomized controlled trial
Conclusions: After a 12-week course of PT once per week for UI, PT group participants had a 75% reduction in weekly median number of leakage episodes, whereas the control group's condition had no improvement. At 1 year, the PT group participants maintained this improvement, whereas the control group's incontinence worsened. (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus
Conclusions: There is no difference in bone mass values or bone turnover process between Iranian postmenopausal women with or without diabetes. (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Effectiveness of a 2-year menopause medicine curriculum for obstetrics and gynecology residents
Objective: Previous work has shown American obstetrics and gynecology (OB/GYN) residents are lacking in menopause training. Our objective was to assess the effectiveness of a 2-year menopause medicine curriculum in improving OB/GYN residents’ knowledge and self-assessed competency in menopause topics. Methods: We developed a menopause medicine-teaching curriculum for OB/GYN residents at our academic hospital-based residency program. The 2-year curriculum was composed of year 1: four 1-hour lectures and one 2-hour lab with cases presentations, and year 2: three 1-hour lectures and one 2-hour lab. Core topics included...
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial
Objective: To evaluate the effect of isolated vitamin D supplementation (VITD) on the rate of falls and postural balance in postmenopausal women fallers. Methods: In this double-blind, placebo-controlled trial, 160 Brazilian younger postmenopausal women were randomized into two groups: VITD group, vitamin D3 supplementation 1,000 IU/day/orally (n = 80) and placebo group (n = 80). Women with amenorrhea at least 12 months, age 50 to 65 years, and a history of falls (previous 12 months) were included. Those with neurological or musculoskeletal disorders, vestibulopathies, drugs use that could affect balance and osteoporo...
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition
Conclusions: These data suggest that estradiol variability may enhance emotional sensitivity to psychosocial stress, particularly sensitivity to social rejection. Combined with VSLEs proximate to the menopausal transition, this increased sensitivity may contribute to the development of depressed mood. (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
Objective: The aim of this study is to confirm the local beneficial effects of intravaginal dehydroepiandrosterone (DHEA, Prasterone) on moderate to severe dyspareunia or pain at sexual activity, the most frequent symptom of vulvovaginal atrophy due to menopause or genitourinary syndrome of menopause (GSM). Methods: In a prospective, randomized, double-blind, and placebo-controlled phase III clinical trial, the effect of daily intravaginal 0.50% DHEA (6.5 mg) (Prasterone, EndoCeutics) was examined on four coprimary objectives, namely percentage of parabasal cells, percentage or superficial cells, vaginal pH, and moderat...
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Resident education in menopause: why it is important and how we can best achieve it
No abstract available (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Editorials Source Type: research

Association between vitamin D and falls in young postmenopausal women
No abstract available (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Editorials Source Type: research

Hormonal-stress interactions in precipitating perimenopausal depressive symptoms
No abstract available (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Editorials Source Type: research

Is vaginal administration the “way out” of the hormone of controversy?
No abstract available (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: Editorials Source Type: research

Thomas B. Clarkson Jr, DVM (June 13, 1931–December 1, 2015)
No abstract available (Source: Menopause)
Source: Menopause - February 27, 2016 Category: OBGYN Tags: In Memoriam Source Type: research

Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review
Conclusions: AMH is currently the most promising marker for ANM prediction. The predictive capacity of mother's ANM demonstrated in a single study makes this marker a promising contributor to AMH for menopause prediction. Models, however, do not predict the extremes of menopause age very well and have wide prediction interval. These markers clearly need improvement before they can be used for individual prediction of menopause in the clinical setting. Moreover, potential limitations for such use include variations in AMH assays used and a lack of correction for factors or diseases affecting AMH levels or ANM. Future studie...
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Review Articles Source Type: research

Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy
Conclusions: The DQSA and its reinforcement of §503A of the FDCA solidifies FDA authority to enforce FDCA provisions against compounders of CBHT. The new law may improve compliance and accreditation by the compounding industry; support state and FDA oversight; and prevent the distribution of misbranded, adulterated, or inconsistently compounded medications, and false and misleading claims, thus reducing public health risk. (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Review Articles Source Type: research

Armodafinil for fatigue associated with menopause: an open-label trial
Conclusions: These preliminary results suggest a therapeutic effect of armodafinil on fatigue affecting quality of life during menopause, and a potential benefit for other menopause-related symptoms. (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Brief Report Source Type: research

Asian Elm tree inner bark prevents articular cartilage deterioration in ovariectomized obese rats with monoiodoacetate-induced osteoarthritis
Objective: We investigated whether long-term consumption of Korean mistletoe or Asian Ulmi cortex would prevent or delay menopausal symptoms and progression of osteoarthritis in estrogen-deficient obese rats. Methods: Ovariectomized (OVX) rats were provided a 45% fat diet containing either (1) 0.6% lyophilized water extract of Korean mistletoe (KME) + 1.4% dextrose (KME; n = 10), (2) 2% lyophilized water extract of Ulmi cortex (UCE; n = 10), (3) 30 μg/kg bw 17β-estradiol + 2% dextrose (positive control; n = 10), (4) 2% dextrose (placebo; OVX-control; n = 10), or (5) 2% dextrose (normal-co...
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer
This study included 712 oophorectomy cases and 163 nonoophorectomy cases. Archived records were reviewed for participant demographics, medical comorbidities, operative notes, histology results, and radiology reports for NAFLD. Cumulative risks of NAFLD after surgical operation were correlated to demographics and medical comorbidities. Results: The cumulative prevalence of NAFLD in 875 women with endometrial tumor was 14.1%, 20.5%, and 38.4% at 1, 2, and 5 years after surgical operation, respectively. On multivariate analysis, after controlling for age, ethnicity, body mass index, medical comorbidities, tumor type, hormona...
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

The effects of menopausal health training for spouses on women's quality of life during menopause transitional period
Objective: Spouses’ support during menopausal transition has an important role for improving the quality of life in postmenopausal women. Since the first step in providing support is having adequate knowledge, this study aimed to investigate the effects of an educational program on menopause health for spouses on women's quality of life during the menopausal transition. Methods: This clinical trial was conducted in Yazd, Iran. A hundred healthy women aged 45 to 60 years were recruited by random sampling. The spouses in the intervention group (n = 50) attended three training sessions about the management and heal...
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Association of obstructive sleep apnea risk factors with nocturnal enuresis in postmenopausal women
Conclusions: OSA risk factors are associated with nocturnal enuresis in postmenopausal women. Mechanisms relating nocturnal enuresis to OSA may include apnea-associated changes in intrathoracic pressure, leading to increased urine output. Questioning at-risk postmenopausal women presenting with nocturnal enuresis about other OSA risk factors should be considered. (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Oral contraceptive use and fracture risk around the menopausal transition
Conclusions: The current study does not show an association between fractures near the menopausal transition and OC use in the decade before menopause or after age 38. For women considering OC use at these times, fracture risk does not seem to be either reduced or—reassuringly—increased. (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Symptom clusters among MsFLASH clinical trial participants
Conclusions: Women meeting hot flash frequency criteria for inclusion in clinical trials exhibited multiple co-occurring symptoms that clustered into identifiable groups according to symptom interference and severity. Variability of symptom profiles between the classes was evident, indicating that the classes were composed of differing symptom types and not simply differing severity levels. These symptom clusters may be useful phenotypes for differentiating treatment effects or evaluating associations with biomarkers or genes. (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study
Objective: Observational studies have suggested that arterial distensibility decreases during menopause; however, its relationship with hormone therapy use remains controversial. We prospectively studied distensibility and hormone therapy use at different menopause stages. Methods: One hundred sixty-one women (aged between 42 and 61 y) without cardiovascular disease underwent carotid artery measurements by ultrasound to calculate distensibility index at baseline and 3 years later. Menopause stage was classified at each visit as premenopausal, perimenopausal, and postmenopausal. Across 3 years of prospective observation, w...
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study
Conclusions: Collectively, these and prior data do not suggest a substantial impact of hysterectomy, with or without BSO, on the risk of VT among postmenopausal women. (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions
Conclusions: Prophylactic BSO during hysterectomy is a significant independent risk factor for worsening skin laxity/sagging and texture/dryness in premenopausal women undergoing hysterectomy for benign conditions. Prophylactic BSO in the presence of dermatological conditions is also associated with reduced quality of life. (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Differential effects of selective estrogen receptor modulators on the vagina and its supportive tissues
This study explored the effects of five SERMs on the function and matrix components of the vagina and its supportive tissues. Methods: Fifty-six rats were administered SERMs by oral gavage for 8 weeks (n = 8 for each SERM): raloxifene, tamoxifen, idoxifene, bazedoxifene at three different doses, and bazedoxifene with conjugated estrogens. Thirty-two rats were used as controls (n = 8 per group): sham operation (no ovariectomy), ovariectomy only, ovariectomy with vehicle gavage, and 17β-estradiol (subcutaneous). Vaginal supportive tissue complex was tested by uniaxial tensile testing. Total collagen content (hy...
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation
Conclusions: Hysterectomy with ovarian conservation is associated with cardiovascular risk factors, particularly obesity. Obesity may contribute to underlying gynecologic conditions leading to hysterectomy; however, surgical selection may also play a role. (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research

Human skin: a mirror for estrogen action?
No abstract available (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Editorials Source Type: research

Lack of a functional response to SERM treatment in ovariectomy-induced vaginal remodeling
No abstract available (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Editorials Source Type: research

Is there a relationship between cardiovascular risk factors and hysterectomy?
No abstract available (Source: Menopause)
Source: Menopause - January 28, 2016 Category: OBGYN Tags: Editorials Source Type: research

Contraception for midlife women
Despite a decline in fertility, women of older reproductive age who do not desire pregnancy should use contraception until menopause. Unintended pregnancy can be disruptive at any age, but in older women, pregnancy is associated with higher rates of adverse health outcomes for the mother and the fetus because of advanced age and comorbid medical conditions (eg, hypertension or diabetes). Therefore, providing appropriate contraceptive care to women of older reproductive age is critical. (Source: Menopause)
Source: Menopause - December 23, 2015 Category: OBGYN Tags: NAMS Practice Pearl Source Type: research

Differences in age at death according to smoking and age at menopause
Conclusions: Younger age at menopause is linearly associated with shorter survival. This association tends to be stronger among current smokers. (Source: Menopause)
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Brief Report Source Type: research

MicroRNA-125a-5p induces mouse granulosa cell apoptosis by targeting signal transducer and activator of transcription 3
Conclusions: Overexpression of miR-125a-5p promotes mGC apoptosis by targeting STAT3. Our findings imply the important role of miR-125a-5p in the pathogenesis of premature ovarian failure. (Source: Menopause)
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Changes in bone mass during the perimenopausal transition in naturally menopausal cynomolgus monkeys
Conclusions: Unlike the ovariectomized monkey models that do not retain the perimenopausal transition, naturally menopausal monkeys elicit different patterns of bone loss during the transition—an abrupt decline in the trabecular metaphysis and a gradual decline in the cortical diaphysis. Naturally menopausal cynomolgus monkeys offer an alternative model for osteoporosis research for postmenopausal women. (Source: Menopause)
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women
This study was conducted to determine, using the HPV DNA Chip (HDC) test, whether the human papillomavirus (HPV) genotype is predictive of recurrent high-grade cervical intraepithelial neoplasia (CIN; CIN2-3) after a loop electrosurgical excision procedure (LEEP) in postmenopausal women. Methods: Between January 2007 and February 2013, 206 postmenopausal women with CIN2-3 were treated with LEEP, followed by cytology, Hybrid Capture II (HC2) assay, and HDC test. Post-LEEP follow-up was performed at 3, 6, 9, 12, 18, and 24 months during the first 2 years and yearly thereafter. Results: Among 206 women, HC2 yielded positive r...
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Longitudinal analysis of associations between women's consultations with complementary and alternative medicine practitioners/use of self-prescribed complementary and alternative medicine and menopause-related symptoms, 2007-2010
Conclusions: Consultations with CAM practitioners and use of self-prescribed CAM among naturally or surgically postmenopausal women are associated with menopause-related symptoms. Our study findings should prompt healthcare providers, in particular family medicine practitioners, to be cognizant of clinical evidence for CAM typically used for the management of common menopause-related symptoms in their aim to provide safe, effective, and coordinated care for women. (Source: Menopause)
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Relationship between menopause status, attitude toward menopause, and quality of life in Chinese midlife women in Hong Kong
Conclusions: Postmenopausal women tended to have more positive attitude toward menopause. Although menopause status did not seem to be associated with QoL, attitude toward menopause, self-reported health status, as well as social and lifestyle factors were associated with QoL in Chinese midlife women. (Source: Menopause)
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Duration of ovarian hormone exposure and atherosclerotic cardiovascular disease in Korean women: the Korean Heart Study
Objective: Although reproductive and hormonal factors, such as menarche and menopause, have been reported as independent risk factors for atherosclerotic cardiovascular disease (ASCVD), few studies have examined these factors in East Asian populations. In the Korean Heart Study, ASCVD risk related to duration of ovarian hormone exposure was examined in a cohort of 66,104 Korean women. Methods: Study members were recruited from participants of routine health examinations at health promotion centers across South Korea in 1996-2004. Ovarian hormone exposure was defined as duration between menarche and menopause. Incidence rat...
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Effects of long-term risedronate treatment on serum ferritin levels in postmenopausal women with osteoporosis: the impact of cardiovascular risk factor load
Objective: Although ferritin has been considered as a possible link between accelerated bone loss and atherosclerosis, the long-term impact of therapeutic agents widely used to treat osteoporosis, such as bisphosphonates, on ferritin levels has not been investigated. The present study investigated the effects of risedronate on serum ferritin levels in postmenopausal women with osteoporosis. Methods: : In an open-label, prospective, uncontrolled study, 68 postmenopausal women with osteoporosis were evaluated. Study participants received risedronate orally at a dose of 35 mg/week during a 6-month treatment period. Blood sa...
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel
This study aims to evaluate the sexual function and quality of life (QoL) of naturally postmenopausal women affected by genitourinary syndrome of menopause who were treated with an ultralow-concentration estriol vaginal gel (0.005%). Methods: Postmenopausal women with vulvovaginal atrophy symptoms and sexual disorders were enrolled in a case-control study. Women were treated with vaginal gel (containing 50 μg of estriol) daily for 3 weeks and then twice weekly up to 12 weeks. Determination of vaginal maturation index, evaluation of vaginal pH, and assessment of vaginal atrophy symptoms were carried out. QoL, sexual fu...
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Predictors of impact of vaginal symptoms in postmenopausal women
Conclusions: Findings suggest that special efforts should be made to identify and treat vaginal symptoms in postmenopausal women known to have depression or urinary incontinence, as these women may experience greater impact of vaginal symptoms on multiple domains of functioning and quality of life. (Source: Menopause)
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research

Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer
Objective: The aim of this study was to evaluate the impact of aromatase inhibitor (AI) treatment on vertebral morphology by vertebral fracture assessment in postmenopausal women with early-stage breast cancer. Methods: A clinical cross-sectional study was conducted. A group of 156 postmenopausal women with breast cancer (mean [SD] age, 60.4 [10.1] y; mean [SD] time since menopause, 11.7 [9.2] y) was included in the study. Eighty-two women received AI treatment, whereas 74 women did not. Women underwent extensive medical history check and risk factor assessment together with vertebral morphology and bone mineral density (B...
Source: Menopause - December 23, 2015 Category: OBGYN Tags: Original Articles Source Type: research